Free Trial

Electromed (ELMD) Competitors

Electromed logo
$29.81 +1.16 (+4.05%)
(As of 11:27 AM ET)

ELMD vs. EYE, BVS, FNA, AVNS, BFLY, IRMD, AXGN, SMLR, SIBN, and KIDS

Should you be buying Electromed stock or one of its competitors? The main competitors of Electromed include National Vision (EYE), Bioventus (BVS), Paragon 28 (FNA), Avanos Medical (AVNS), Butterfly Network (BFLY), Iradimed (IRMD), AxoGen (AXGN), Semler Scientific (SMLR), SI-BONE (SIBN), and OrthoPediatrics (KIDS). These companies are all part of the "medical equipment" industry.

Electromed vs.

National Vision (NASDAQ:EYE) and Electromed (NYSE:ELMD) are both small-cap consumer staples companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, community ranking, dividends, media sentiment, valuation and earnings.

Electromed has lower revenue, but higher earnings than National Vision. National Vision is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Vision$2.18B0.40-$65.90M-$0.20-54.85
Electromed$57.06M4.25$5.15M$0.7239.79

National Vision has a beta of 1.41, indicating that its share price is 41% more volatile than the S&P 500. Comparatively, Electromed has a beta of 0.28, indicating that its share price is 72% less volatile than the S&P 500.

Electromed has a net margin of 11.34% compared to National Vision's net margin of -0.81%. Electromed's return on equity of 15.32% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
National Vision-0.81% 3.52% 1.39%
Electromed 11.34%15.32%13.13%

National Vision currently has a consensus target price of $14.00, indicating a potential upside of 27.62%. Given National Vision's stronger consensus rating and higher probable upside, equities analysts clearly believe National Vision is more favorable than Electromed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Vision
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
Electromed
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

National Vision received 241 more outperform votes than Electromed when rated by MarketBeat users. However, 86.67% of users gave Electromed an outperform vote while only 65.63% of users gave National Vision an outperform vote.

CompanyUnderperformOutperform
National VisionOutperform Votes
254
65.63%
Underperform Votes
133
34.37%
ElectromedOutperform Votes
13
86.67%
Underperform Votes
2
13.33%

In the previous week, National Vision had 9 more articles in the media than Electromed. MarketBeat recorded 9 mentions for National Vision and 0 mentions for Electromed. National Vision's average media sentiment score of 1.33 beat Electromed's score of 0.00 indicating that National Vision is being referred to more favorably in the media.

Company Overall Sentiment
National Vision Positive
Electromed Neutral

40.8% of Electromed shares are held by institutional investors. 2.3% of National Vision shares are held by insiders. Comparatively, 14.0% of Electromed shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Electromed beats National Vision on 10 of the 18 factors compared between the two stocks.

Get Electromed News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ELMD vs. The Competition

MetricElectromedElectromedical equipment IndustryMedical SectorNYSE Exchange
Market Cap$242.32M$3.14B$5.20B$19.21B
Dividend YieldN/A1.77%5.12%3.66%
P/E Ratio39.7917.1587.0741.07
Price / Sales4.2552.731,159.6717.39
Price / Cash41.6239.9343.2321.28
Price / Book5.563.794.805.31
Net Income$5.15M$89.83M$120.46M$989.88M
7 Day Performance2.10%0.85%-0.91%-2.50%
1 Month Performance-3.83%-0.91%14.91%-4.68%
1 Year Performance169.27%0.96%29.59%11.56%

Electromed Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELMD
Electromed
N/A$29.81
+4.0%
N/A+169.3%$252.13M$57.06M41.40174
EYE
National Vision
3.7144 of 5 stars
$11.60
+1.7%
$14.00
+20.7%
-44.9%$913.50M$2.13B-57.0513,998Positive News
BVS
Bioventus
3.6159 of 5 stars
$11.25
+2.0%
$16.00
+42.2%
+103.6%$912.99M$555.06M-18.081,200Positive News
FNA
Paragon 28
3.0831 of 5 stars
$10.59
+1.6%
$15.60
+47.3%
-19.0%$886.60M$245.00M-14.08343,000
AVNS
Avanos Medical
2.8353 of 5 stars
$17.87
-0.6%
N/A-29.7%$821.31M$673.30M52.853,771
BFLY
Butterfly Network
0.6001 of 5 stars
$3.55
+4.7%
$3.00
-15.5%
+184.9%$756.37M$76.22M-7.37460
IRMD
Iradimed
4.5107 of 5 stars
$53.44
+1.5%
$60.00
+12.3%
+16.7%$677.09M$65.56M36.05110
AXGN
AxoGen
1.0651 of 5 stars
$14.39
+1.6%
$15.00
+4.2%
+145.6%$633.28M$180.86M-44.47426News Coverage
Positive News
SMLR
Semler Scientific
1.285 of 5 stars
$74.71
+11.2%
N/A+42.7%$619.35M$68.18M35.2792Gap Up
High Trading Volume
SIBN
SI-BONE
4.3217 of 5 stars
$13.94
+3.9%
$23.00
+65.0%
-37.4%$584.64M$138.89M-14.59350
KIDS
OrthoPediatrics
3.7922 of 5 stars
$22.40
+1.3%
$40.00
+78.6%
-36.1%$542.53M$148.73M-17.98200

Related Companies and Tools


This page (NYSE:ELMD) was last updated on 12/24/2024 by MarketBeat.com Staff
From Our Partners